+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry

Joint Bone Spine 80(2): 160-164

In Switzerland, the prescription of biologic antirheumatic agents in rheumatoid arthritis (RA) patients is not limited by stringent requirements from health authorities. The goals of this study were to: determine the characteristics of the Swiss patients at the initiation of biologics, compare them with other countries and evaluate whether different disease activity levels at initiation of therapy, resulting from distinct access to these treatment, influence their effectiveness. This is a retrospective cohort study of RA patients followed in the Swiss register (SCQM-RA). Two thousand and sixty patients treated with biologics were retrieved. We present the disease characteristics and the patients' demographic data, at initiation and some effectiveness data after 1 year of treatment. Two thousand and sixty patients treated with biologics were retrieved. At initiation of treatment, the mean disease activity DAS (SD): 4.4 (1.4), number of previous antirheumatic treatments: 1.1, functional status HAQ: 1.1 (0.7) and median duration of illness: 5.5 years were significantly lower than in other published registries. The mean DAS: 3.3 (1.4) 1 year after initiation of therapy also appears lower than in other countries. Additionally, patients treated more recently (after 2005) had a significantly higher improvement in mean DAS. Data from the Swiss RA registry demonstrate that biologics are prescribed at a lower level of disease activity and after fewer prior DMARD failures than in most other countries, a practice that seems to correlate with overall lower absolute levels of disease activity and better patient outcomes after 1 year of treatment.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036479877

Download citation: RISBibTeXText

PMID: 22771133

DOI: 10.1016/j.jbspin.2012.05.003

Related references

AB1366Prevalence of rheumatoid arthritis and spondyloarthropathy in belgrade, serbia. Annals of the Rheumatic Diseases 71(Suppl 3): 716.1-716, 2013

Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre. Journal of Ayub Medical College Abbottabad 20(2): 39-42, 2008

THU0603Performance of The 2013 American College of Rheumatology/european League against Rheumatism Systemic Sclerosis Classification Criteria. Annals of the Rheumatic Diseases 75(Suppl 2): 410.1-410, 2016

Does addition of crosslink to pedicle-screw-based instrumentation impact the development of the spinal canal in children younger than 5 years of age?. European Spine Journal 24(7): 1391-1398, 2016

Impact of Treatment Type on Overall Survival in ElderlyBrazilian Women with Breast Cancer. Asian Pacific Journal of Cancer Prevention 17(10): 4769-4774, 2016

AB0514Efficacy and Safety of Tofacitinib in Chinese Patients with Active Rheumatoid Arthritis: Subgroup Analysis from a Phase 3 Study of Tofacitinib in Combination with Nonbiologic Disease-Modifying Antirheumatic Drugs. Annals of the Rheumatic Diseases 74(Suppl 2): 1071-1071, 2015

SAT0079 The analysis of fecal microbiota in rheumatoid arthritis patients compared to healthy volunteers using bacterial RRNA-targeted reverse transcription-quantitative PCR. Annals of the Rheumatic Diseases 71(Suppl 3): 496-496, 2012

Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study. Journal of Bone and Mineral Research 31(8): 1596-1607, 2016

AB0466The Outcome of Tocilizumab Treatment with Achievement of Glucocorticoids Withdrawal Against Rheumatoid Arthritis for 24 Months from TBC Registry. Annals of the Rheumatic Diseases 74(Suppl 2): 1051.3-1052, 2015

Treatment patterns of elderly breast cancer patients at two Canadian cancer centres. European Journal of Surgical Oncology 41(5): 625-634, 2015

Early clinical predictors of intractable epilepsy in childhood. Turkish Journal of Medical Sciences 44(3): 490-495, 2014

Ten-year reinvestigation of ocular manifestations in Marfan syndrome. Clinical and Experimental Ophthalmology 47(2): 212-218, 2019

Low rates of antimicrobial-resistant Enterobacteriaceae in wildlife in Taï National Park, Côte d'Ivoire, surrounded by villages with high prevalence of multiresistant ESBL-producing Escherichia coli in people and domestic animals. Plos one 9(12): E113548, 2014

An oral Sindbis virus replicon-based DNA vaccine containing VP2 gene of canine parvovirus delivered by Escherichia coli elicits immune responses in dogs. Acta Virologica 55(4): 289-294, 2011

FRI0173Efficacy of Sarilumab in Moderate and Severe Rheumatoid Arthritis as Defined by Baseline DAS28-CRP Scores: The Mobility Study. Annals of the Rheumatic Diseases 74(Suppl 2): 486.2-486, 2015